Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 13 studies | 28% ± 11% | |
| oligodendrocyte | 6 studies | 23% ± 6% | |
| microglial cell | 4 studies | 21% ± 3% | |
| epithelial cell | 4 studies | 25% ± 5% | |
| astrocyte | 4 studies | 28% ± 6% | |
| adipocyte | 4 studies | 24% ± 1% | |
| GABAergic neuron | 3 studies | 33% ± 8% | |
| glutamatergic neuron | 3 studies | 38% ± 11% | |
| oligodendrocyte precursor cell | 3 studies | 22% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 5 studies | 29% ± 9% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 3222.82 | 245 / 245 | 100% | 10.59 | 502 / 502 |
| breast | 100% | 3658.11 | 459 / 459 | 100% | 14.72 | 1116 / 1118 |
| thymus | 100% | 5441.90 | 653 / 653 | 100% | 13.78 | 603 / 605 |
| adrenal gland | 100% | 5453.81 | 258 / 258 | 100% | 13.98 | 229 / 230 |
| ovary | 100% | 3966.28 | 180 / 180 | 99% | 8.40 | 424 / 430 |
| bladder | 100% | 3358.38 | 21 / 21 | 98% | 10.60 | 496 / 504 |
| brain | 98% | 1606.44 | 2600 / 2642 | 100% | 12.74 | 705 / 705 |
| kidney | 100% | 3356.07 | 89 / 89 | 98% | 15.25 | 886 / 901 |
| pancreas | 99% | 1374.77 | 326 / 328 | 98% | 10.53 | 175 / 178 |
| lung | 100% | 3033.27 | 578 / 578 | 97% | 10.47 | 1121 / 1155 |
| intestine | 100% | 2762.28 | 966 / 966 | 96% | 8.14 | 504 / 527 |
| stomach | 100% | 2049.33 | 359 / 359 | 95% | 8.19 | 271 / 286 |
| skin | 100% | 2383.00 | 1808 / 1809 | 95% | 9.26 | 447 / 472 |
| uterus | 100% | 3881.72 | 170 / 170 | 90% | 9.05 | 414 / 459 |
| esophagus | 100% | 2736.07 | 1444 / 1445 | 89% | 9.25 | 162 / 183 |
| liver | 98% | 1360.56 | 221 / 226 | 56% | 3.14 | 228 / 406 |
| adipose | 100% | 3714.25 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 9.51 | 29 / 29 |
| spleen | 100% | 6939.52 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 3.32 | 1 / 1 |
| blood vessel | 100% | 2759.74 | 1334 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 1874.49 | 858 / 861 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 6.14 | 43 / 45 |
| muscle | 95% | 967.39 | 763 / 803 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 80% | 5.28 | 64 / 80 |
| peripheral blood | 71% | 1382.83 | 659 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0030097 | Biological process | hemopoiesis |
| GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
| GO_0005634 | Cellular component | nucleus |
| GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
| GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
| GO_0046872 | Molecular function | metal ion binding |
| Gene name | ZNF160 |
| Protein name | Zinc finger protein 160 Zinc finger protein 160 (Zinc finger protein HZF5) (Zinc finger protein Kr18) (HKr18) |
| Synonyms | hCG_19658 KIAA1611 |
| Description | FUNCTION: May be involved in transcriptional regulation. |
| Accessions | M0QXU9 ENST00000355147.9 [Q9HCG1-2] ENST00000601421.5 ENST00000418871.5 [Q9HCG1-1] ENST00000599247.5 M0QZI7 ENST00000599056.5 [Q9HCG1-1] M0QZ49 Q9HCG1 ENST00000601982.5 ENST00000683776.1 [Q9HCG1-1] ENST00000429604.5 [Q9HCG1-1] |
